HIGHLIGHTS
- who: Wenrui Yang from the (UNIVERSITY) have published the research: Hetrombopag plus porcine ATG and cyclosporine for the treatment of aplastic anaemia: early outcomes of a prospective pilot study, in the Journal: (JOURNAL)
- how: A small molecular thrombopoietin-receptor agonist has shown encouraging efficiency in refractory or relapsed severe To investigate the response rate of combined with IST as first-line treatment the authors designed a prospective pilot study including 32 patients with SAA treated with anti-human T lymphocyte porcine immunoglobulin (p-ATG) cyclosporine and The methods of this study were described in Additional . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.